RTI Surgical buys Zyga Tech and its SImmetry sacroiliac fusion device, updates 2018 outlook

January 5, 2018 By Fink Densford Leave a Comment

RTI Surgical (NSDQ:RTIX) yesterday announced an agreement to purchase Zyga Technology and its SImmetry sacroiliac joint fusion system and today released updated guidance for 2018 and beyond.

The Alachua, Fla.-based RTI surgical said that Zyga Technology has approximately 30 employees and $4 million in annual revenue, and that it plans to fund the acquisition through a combination of cash and through borrowing under its existing credit facility.

Terms of the deal were not disclosed, and RTI Surgical it expects the deal to close when the Delaware Department of State re-opens as it is currently closed due to inclement weather.

“Acquiring Zyga Technology further advances our strategic transformation focused on reducing complexity, driving operational excellence and accelerating growth. We are increasing our focus on both internal development and external investment, and acquiring Zyga Technology’s innovative minimally invasive treatment both accentuates our robust spine portfolio and opens significant opportunities to accelerate growth. The acquisition provides access to a procedure that has been growing in excess of 20% in recent years and leverages the core competencies of our Spine franchise. We believe it is perfectly aligned with our Spine-focused expansion strategy to pursue niche differentiated products, to gain scale and customer retention and support portfolio pull-through along the way. As part of the RTI team, we believe Zyga has the potential to produce significant growth by gaining market share, growing procedure volume and driving increased adoption. SImmetry is a differentiated product designed to drive fusion and supported by clinical data and, with access to RTI’s larger, sophisticated sales force, we will introduce the system to a much wider surgeon audience,” prez & CEO Camille Farhat said in a prepared release.

The company today laid out its guidance and long term goals for 2018 and beyond, expecting to see revenues for 2018 between $280 million and $290 million, with full year EBITDA between $32 million and $38 million.

“We expect 2018 will be a year of continued progress with the accelerating implementation of our strategic transformation plans. Our guidance reflects the early results of our initiatives and the ongoing investments necessary to produce sustainable profitable growth and improved cash flow,” CEO Farhat said in a prepared statement.

Beyond 2018, the company said it is hopeful to achieve $500 million in revenue within 5 years, with doubled EBITDA margin moving up to more than 20%.

“We expect the initiatives we began to reduce complexity and drive operational excellence in 2017 to produce improving margins and cash flow in our tissue focused operations in the coming years. This expected improvement in financial performance will allow us to fund organic and acquisitive growth in our spine focused operations. We are committed to driving significant financial improvements and increasing long-term shareholder value,” CEO Farhat said in a press release.

Last November, RTI Surgical revealed a warning letter it received from the FDA related to processes used to manufacture its Map3 cellular allogeneic bone graft over issues with the regulatory classification of the product.

DeviceTalks Boston is Bigger and Better than Ever!

Join us Oct. 8-10 for the 7th annual DeviceTalks Boston, back in the city where it all began.

DeviceTalks offers three days of world-class education, networking, and a technology exhibition featuring the leading companies in the industry.

Early Registration is now open.

Hemco touts HEPA-filtered enclosures
Hemco is touting its HEPA-filtered enclosures designed for packaging and handling powders. The enclosures are designed to isolate powder handling, sample weighing, high throughput screening and other lab automated processes. Enclosures typically feature HEPA-filtered exhaust or HEPA-filtered systems to help protect users or products depending on the process it goes through. Hemco enclosures are available […]
Medtech companies raised more than $738 million in Q2
Venture capital firms invested more than $738 million during the second quarter of 2018, $1 million less than the first quarter of this year, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There was a total of 61 deals during Q2, an increase from the 48 that the industry saw during Q1. […]
8 crowdfunded health devices you need to know
Companies including 3M and Aura Medical are turning to the popular websites Kickstarter and Indiegogo to get their ideas crowdfunded by people who want them to come to life. The idea behind a crowdfunding website is that if you back the project and donate a certain amount of money, you’ll get something in return, oftentimes […]
China FDA accepting MDCO certificates from Hong Kong-based medical device registration applicants
By Stewart Eisenhart, Emergo Group The China Food and Drug Administration (CFDA) has begun recognizing certain certifications issued by the Hong Kong Medical Device Control Office (MDCO) for country-of-origin requirements. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the author’s only and do not necessarily […]
This bioprinter could screen bacterial infections in minutes
Stanford researchers are developing a bioprinter that, when paired with an advanced bacteria scanner, could speed up screening for bacteria infections. The bioprinter consists of acoustic pulses that shoot through blood samples of a patient. The pulses push individual blood droplets onto a piece of paper. Tens of millions are printed on the final print, […]
Cadence expands electromechanical grinding tech at R.I. facility
Cadence (Staunton, Va.) has expanded its electrochemical grinding technology at its Cranston, R.I. facility, the company said today. The new equipment uses high -precision, burr-free grinding with CNC control, enabling robust processing of harder materials such as spring-tempered steel and heat treated stainless steel for profile grinding- shavers and related products. “This latest technology allows us to […]
Instron to host biomedical open house
Instron announced that it plans to host a biomedical open house event on Sept. 20 at its Norwood, Mass. headquarters. The open house event will showcase the company’s advances in static, dynamic and impact testing for the biomedical field. It will include live demonstrations on how to improve efficiency in the lab, ways to expand […]
Medtronic warns on connectivity issue with Guardian Connect app
Medtronic (NYSE:MDT) this month issued a letter to physicians warning them of a potential connectivity issue with the Guardian Connect mobile app. The medtech giant warned that people using the Guardian Connect system to keep track of their blood sugar levels should update to the latest version of the mobile app as soon as possible. Get […]
Swiss regulators to overhaul export certification system
By Stewart Eisenhart, Emergo Group Swissmedic, Switzerland’s medical device market regulator, will replace its current processes for issuing export certificates as well as manufacturing certificates with an online system in order to prevent delays and free up resources. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post […]
Sterigenics expands in the U.K.
Sterigenics today announced plans to build a new facility in the Chesterfield/Derbyshire, U.K.’s Markham Vale North area as the company looks to expand its footprint in Europe. The 60,000 square-foot facility is expected to be completed by the fourth quarter of 2018, with plans to install a Nordion JS10000 gamma irradiator with a research loop, […]
National Guideline Clearinghouse to live on despite feds bowing out
The nonprofit that has run the recently shuttered National Guideline Clearinghouse (NGC) for 20 years plans to replace the website and run it privately. Funding to support the federal Agency for Healthcare Research and Quality’s (AHRQ) clinical practice guideline website ended on July 16. ECRI Institute, which developed and maintained NGC since its inception in […]